Ajanta Pharma Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
11,783
14,530
17,140
19,164
20,596
Cost of Goods Sold (COGS) incl. D&A
5,424
6,162
7,018
7,617
8,452
Gross Income
6,359
8,368
10,122
11,548
12,144
SG&A Expense
3,401
4,104
4,758
5,468
6,600
EBIT
2,948
4,261
-
-
5,534
Unusual Expense
-
85
55
64
31
Non Operating Income/Expense
338
332
12
462
656
Interest Expense
87
59
49
14
4
Pretax Income
3,299
4,560
5,589
6,482
6,226
Income Tax
960
1,462
1,433
1,413
1,539
Consolidated Net Income
2,339
3,099
4,156
5,068
4,686
Net Income
2,339
3,099
4,156
5,068
4,686
Net Income After Extraordinaries
2,339
3,099
4,156
5,068
4,686
Net Income Available to Common
2,339
3,099
4,156
5,068
4,686
EPS (Basic)
26.62
35.24
47.23
57.59
53.25
Basic Shares Outstanding
88
88
88
88
88
EPS (Diluted)
26.57
35.20
47.23
57.58
53.24
Diluted Shares Outstanding
88
88
88
88
88
EBITDA
3,387
4,777
6,004
6,686
6,130
Other Operating Expense
9
3
196
5
10
Non-Operating Interest Income
99
111
35
24
10
About Ajanta Pharma
View Profile
